SEROPROTECTION AGAINST VACCINE-PREVENTABLE INFECTIONS IN CAR T-CELL RECIPIENTS: LOWER BASELINE TITERS IN BCMA- VERSUS CD19-CAR T PATIENTS PERSIST AFTER THERAPY

EHA Library, Giulia Magno, 4206866

PRIMARY PROPHYLAXIS WITH IMMUNOGLOBULIN-REPLACEMENT THERAPY IMPROVES INFECTION-FREE AND OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH B-CELL MATURATION ANTIGEN BISPECIFIC ANTIBODIES

EHA Library, Antoine Azar, 4206867

SICKLE CELL DISEASE IN EUROPE: A CROSS-BORDER REAL-WORLD DATA ANALYSIS FROM THE RADEEP REGISTRY

EHA Library, Anna Collado Gimbert, 4206846

RESULTS OF THE PHASE 1B PIONEER STUDY: SAFETY AND EFFICACY OF POCIREDIR IN ADULTS WITH SEVERE SICKLE CELL DISEASE AND HYDROXYUREA INTOLERANCE OR UNRESPONSIVENESS

EHA Library, Modupe Idowu, 4206845

PHASE 1/2 HIBISCUS KIDS STUDY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: SAFETY AND EFFICACY FINDINGS FROM THE COMPLETE FIRST COHORT

EHA Library, Bernhards Ogutu, 4206844

VENETOCLAX SENSITIVITY IN ACUTE MYELOID LEUKAEMIA WITH RUNX1 FRAMESHIFT MUTATIONS RESULTS FROM MITOCHONDRIAL ADAPTATION TO PROTEOSTATIC STRESS

EHA Library, David Palmer, 4206675

CYTOPLASMIC LOCALIZATION OF QKI MEDIATES THERAPUETIC RESISTANCE AND IMMUNE EVASION

EHA Library, Sadik Karma, 4206676

TRANSCRIPTIONALLY DEFINED AML CELL STATES ASSOCIATE WITH TREATMENT RESPONSE AND MICROENVIRONMENTAL REMODELING

EHA Library, Nona Struyf, 4206678

ZIFTOMENIB COMBINED WITH INTENSIVE INDUCTION (7+3) FOR NEWLY DIAGNOSED NPM1‑M OR KMT2A-R ACUTE MYELOID LEUKEMIA (AML): LONG-TERM RESULTS FROM THE KOMET-007 TRIAL

EHA Library, Amer M. Zeidan, 4206684

A PHASE II RANDOMIZED STUDY OF AK117 VERSUS PLACEBO IN COMBINATION WITH VENETOCLAX AND AZACITIDINE IN PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Huafeng Wang, 4206685

HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH HIGH-RISK ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ARSENIC TRIOXIDE. RESULTS FROM THE INTERNATIONAL RANDOMIZED PHASE III APOLLO TRIAL

EHA Library, Fabio Efficace, 4206686

TUSCANY STUDY OF SAFETY AND EFFICACY OF TUSPETINIB PLUS STANDARD OF CARE VENETOCLAX AND AZACITIDINE IN STUDY PARTICIPANTS WITH NEWLY DIAGNOSED AML INELIGIBLE FOR INDUCTION CHEMOTHERAPY

EHA Library, Nikolai Podoltsev, 4206688

UPDATED EFFICACY AND SAFETY DATA FROM AN ONGOING PHASE 1A/B TRIAL OF THE BTK DEGRADER BEXOBRUTIDEG (NX-5948) IN PATIENTS WITH CLL ACROSS LINES OF THERAPY

EHA Library, Talha Munir, 4206704

OUTCOMES OF VENETOCLAX-BASED TREATMENT IN PATIENTS WITH BRUTON TYROSINE KINASE INHIBITOR (BTKI)-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN INTERNATIONAL STUDY CONDUCTED BY ERIC

EHA Library, Thomas Chatzikonstantinou, 4206705

BGB-16673, A BRUTON TYROSINE KINASE (BTK) DEGRADER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): A PHASE 1 CADANCE-101 STUDY UPDATE

EHA Library, Stephan Stilgenbauer, 4206706

DUAL TARGETED LENTIVIRAL TRANSDUCED ANTI-CD20/ANTI-CD19 (LV20.19) CAR T CELLS FOR RELAPSED, REFRACTORY CLL

EHA Library, Nirav N Shah, 4206708

PRE‑TRANSPLANT BLINATUMOMAB AND CAR‑T SHAPE IMMUNE RECONSTITUTION DYNAMICS IN CHILDREN

EHA Library, Silvia Nucera, 4206843

DURABLE CLINICAL BENEFITS WITH RM001 (AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS) FOR TRANSFUSION-DEPENDENT Β-THALASSEMIA

EHA Library, Hui Xu, 4206842

DURABLE RESPONSES AND FAVORABLE SAFETY OF BAFF-R CAR T-CELLS (PMB-CT01) IN PATIENTS WITH RELAPSED/ REFRACTORY B-CELL LYMPHOMAS WITH PRIOR CD19-DIRECTED THERAPY FAILURE OR CD19-NEGATIVE DISEASE

EHA Library, L. Elizabeth Budde, 4206841

CSNK1A1 E98V DRIVES REWIRING OF SIGNALLING AND METABOLISM IN DEL(5Q) MDS

EHA Library, Juliette Pearce, 4206720

LARGE-SCALE SCREENING OF MYELOID NEOPLASTIC PRECURSOR STATES USING BLOOD CELL MORPHOLOGY

EHA Library, Oona RInkinen, 4206721

SELECTIVE EXPANSION OF TET2‑MUTANT CLONAL HEMATOPOIESIS UNDER METFORMIN IS DRIVEN BY ENHANCED MITOCHONDRIAL AND LIPID STRESS TOLERANCE

EHA Library, Silke E. Miedema, 4206722

GENOMIC LANDSCAPE AND PROGNOSTIC IMPACT OF SOMATIC MUTATIONS IN APLASTIC ANEMIA PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiao-Di Ma, 4206734

ELTROMBOPAG ADDED TO COMBINED IMMUNOSUPPRESSIVE THERAPY (IST) IN CHILDREN WITH ACQUIRED SEVERE APLASTIC ANEMIA ACCELERATES HEMATOLOGIC RECOVERY AND SHOULD BE CONTINUED IN THE SECOND COURSE OF IST

EHA Library, Alexey Maschan, 4206736

ELTROMBOPAG PLUS CYCLOSPORINE A FOR MODERATE APLASTIC ANEMIA (EMAA), A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED PHASE 3 TRIAL: TREATMENT MODIFICATIONS AFTER DOUBLE BLIND TREATMENT PERIOD

EHA Library, Britta Höchsmann, 4206738

OL-101, A BCMA/GPRC5D DUAL-TARGETING CAR-T, INDUCES DEEP RESPONSES IN HEAVILY PRETREATED ADVANCED MYELOMA, PARTICULARLY IN PATIENTS POST BCMA- OR GPRC5D-TARGETED THERAPY OR WITH EXTRAMEDULLARY DISEASE

EHA Library, Mingming Zhang, 4206839

MOLECULAR SURVEILLANCE OF AGGRESSIVE LARGE B-CELL LYMPHOMA USING CIRCULATING TUMOR DNA DUPLEXES

EHA Library, Sirpa Leppä, 4206813

INTEGRATED CLINICAL AND GENETIC SCORING REFINES PROGNOSIS IN DARK ZONE SIGNATURE-POSITIVE (DZSIGPOS) DIFFUSE LARGE B-CELL LYMPHOMA: THE DARK ZONE PROGNOSTIC INDEX (DZPI)

EHA Library, Jinhua Liang, 4206812

TUMOR CELL EXPRESSION OF SOX11 AND CYCLIN D1 DIFFERENTLY IMPACT THE SPATIAL TUMOR IMMUNE CELL LANDSCAPE IN MANTLE CELL LYMPHOMA- A TRANSLATIONAL NORDIC MCL2/3 STUDY

EHA Library, June Myklebust, 4206788

CLINICAL IMPACT OF GERMLINE SINGLE-NUCLEOTIDE POLYMORPHISMS IN MANTLE CELL LYMPHOMA: INSIGHTS FROM THE TRIANGLE TRIAL BY THE MULTIPLY CONSORTIUM

EHA Library, Bashar Al Deeban, 4206785

GENOMIC PREDICTORS OF OUTCOME IN MANTLE CELL LYMPHOMA: TP53 AND ADDITIONAL ALTERATIONS IN THE TRIANGLE TRIAL BY THE MULTIPLY CONSORTIUM

EHA Library, Marta Grau, 4206787

FIXED-DURATION GLOFITAMAB MONOTHERAPY IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA WITH OR WITHOUT PRIOR BRUTON'S TYROSINE KINASE INHIBITOR EXPOSURE: UPDATED OUTCOMES WITH 3.5 YEARS OF FOLLOW-UP

EHA Library, Yasmin Karimi, 4206786

CD22-DIRECTED CAR T-CELLS INDUCE HIGH RATES OF COMPLETE REMISSIONS WITH MINIMAL NEUROTOXICITY IN HIGH-RISK FOLLICULAR LYMPHOMA, MANTLE CELL LYMPHOMA, AND OTHER NON-HODGKIN LYMPHOMA SUBTYPES.

EHA Library, Matthew J. Frank, 4206784

HIGH MRD NEGATIVITY RATES AND PROLONGED PFS WITH BELANTAMAB MAFODOTIN PLUS DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE IN TRANSPLANT INELIGIBLE NEWLY-DIAGNOSED MYELOMA: RESULTS OF THE BELA-DRD STUDY

EHA Library, Evangelos Terpos, 4206758

CB-011, AN ALLOGENEIC ANTI-BCMA CAR-T CELL THERAPY WITH IMMUNE CLOAKING, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (CAMMOUFLAGE PHASE 1 TRIAL)

EHA Library, Binod Dhakal, 4206755

DYNAMICS AND CLINICAL IMPACT OF CLONAL HEMATOPOIESIS IN DIFFUSE LARGE B-CELL LYMPHOMA THROUGH MULTI-COMPARTMENT GENOMIC PROFILING

EHA Library, Nawar Maher, 4206809

CIRCULATING TUMOR DNA REVEALS LYMPHOMA-ASSOCIATED MUTATIONS LONG BEFORE CLINICAL DIAGNOSIS

EHA Library, Nick Veltmaat, 4206810

DIAGNOSING PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA THROUGH MOLECULAR AND IMMUNE BIOMARKERS IN CEREBROSPINAL FLUID: A MULTICENTRE PROSPECTIVE COHORT STUDY (PRICELUS)

EHA Library, Josephus van Rooij, 4206811

ARLOCABTAGENE AUTOLEUCEL, A GPRC5D-TARGETED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1 SAFETY AND EFFICACY RESULTS IN PATIENTS WITH 1–3 PRIOR REGIMENS

EHA Library, Susan Bal, 4206754

CLINICAL AND MOLECULAR FINDINGS IN 46 PATIENTS WITH DNAJC21-RELATED BONE MARROW FAILURE SYNDROME

EHA Library, María Muñoz Martínez, 4206737

A PHASE III STUDY OF A HEAD-TO-HEAD COMPARISON OF A FACTOR B INHIBITOR HSK39297, VERSUS ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA NAIVE TO COMPLEMENT INHIBITION

EHA Library, Yawen Zhang, 4206735

GENOMIC ANALYSIS OF PRELEUKEMIC CLONES IDENTIFIES NEW DRIVERS OF MYELOID NEOPLASMS

EHA Library, Martina Sarchi, 4206723

A NEW MOUSE MODEL OF JMML HIGHLIGHTS DIFFERENTIAL SUSCEPTIBILITY OF EMBRYONIC HEMATOPOIETIC STEM/PROGENITOR CELLS TO ONCOGENIC KRASG12D AND IDENTIFIES INFLAMMATION AS A TARGETABLE THERAPEUTIC AXIS

EHA Library, Emanuele Azzoni, 4206719

FIXED DURATION VENETOCLAX PLUS EPCORITAMAB SHOWS FAVORABLE TOLERABILITY AND HIGH RESPONSE RATES WITH EARLY MOLECULAR RESPONSES IN R/R CLL/SLL: INTERIM ANALYSIS OF THE RANDOMIZED HOVON 165/AETHER TRIAL

EHA Library, Arnon Philip Kater, 4206707

CD19/CD22 BISPECIFIC CAR-T CELL THERAPY FOR RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AND MECHANISTIC INVESTIGATION: A PROSPECTIVE, SINGLE-ARM, SINGLE-CENTER, PHASE 2 CLINICAL TRIAL

EHA Library, Liang Wang, 4206840

IN HUMANIZED SICKLE CELL MICE, COLCHICINE PROTECTS AGAINST THE PROGRESSION OF SICKLE CELL CARDIOMYOPATHY

EHA Library, Enrica Federti, 4206847

A PLASMA–PLACENTAL ATLAS OF SICKLE CELL PREGNANCY REVEALS ENDOTHELIAL, COAGULATION, AND COMPLEMENT DYSREGULATION

EHA Library, Alexandra Boye-Doe, 4206848

INTENSIVE CHEMOTHERAPY IN COMBINATION WITH QUIZARTINIB VERSUS MIDOSTAURIN FOR FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA: A MULTICENTER COHORT STUDY

EHA Library, Michelle Lee, 4206687

TEMPORAL TRENDS IN INFECTION-RELATED PROPORTIONAL MORTALITY IN LYMPHOMA: A DANISH POPULATION-BASED STUDY

EHA Library, William Mølgaard Ullahammer, 4206864

HIGH-DOSE VERSUS STANDARD-DOSE INACTIVATED INFLUENZA VACCINE IN OLDER ADULTS WITH HEMATOLOGICAL MALIGNANCIES: SUBGROUP ANALYSIS FROM THE DANFLU-2 RANDOMIZED TRIAL

EHA Library, Christian Brieghel, 4206865

EARLY PROPHYLACTIC RITUXIMAB REDUCED THE INCIDENCE OF EBV INFECTION AND PTLD IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTER STUDY

EHA Library, Ao Zhang, 4206868

ENFORCING FATTY ACID SATURATION IMBALANCE ENHANCES STEAROYL-COA DESATURASE INHIBITION THERAPEUTIC EFFICACY IN ACUTE MYELOID LEUKEMIA

EHA Library, Sirisha Natani, 4206677

A CD22 ANTIGEN SHIFT OCCURS IN VENETOCLAX/AZACITIDINE RESISTANT AML AND FACILITATES TARGETED THERAPY

EHA Library, Josephine Brysting, 4206674

COMPARISON OF END INDUCTION FLOW CYTOMETRY VERSUS HIGH-THROUGHPUT SEQUENCING BASED MINIMAL RESIDUAL DISEASE IN NEWLY DIAGNOSED CHILDHOOD STANDARD RISK B ALL:  A REPORT FROM COG AALL1731

EHA Library, Sumit Gupta, 4206666

IMPROVING EFFICACY AND SAFETY OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN MORPHOLOGIC REMISSION TREATED WITH OBECABTAGENE AUTOLEUCEL (OBE-CEL)

EHA Library, Claire Roddie, 4206667

SAFETY AND EFFICACY OF UCART22 IN HEAVILY PRE-TREATED PATIENTS WITH RELAPSED OR REFRACTORY CD22+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): RESULTS OF THE PHASE 1 BALLI-01 TRIAL

EHA Library, Nitin Jain, 4206668

CD5 INHIBITION AS A GENERALIZABLE STRATEGY TO AMPLIFY T CELL-MEDIATED ANTI-TUMOR EFFECTS OF BISPECIFIC T-CELL ENGAGERS

EHA Library, Weilin Wang, 4206658

TAFASITAMAB PLUS LENALIDOMIDE AND R-CHOP FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): RESULTS FROM THE PHASE 3 FRONTMIND STUDY

EHA Library, Georg Lenz, 4206655

ETAVOPIVAT IMPROVES HEMOGLOBIN LEVELS IN ADULTS AND ADOLESCENTS WITH NON-TRANSFUSION-DEPENDENT ALPHA- OR ΒETA-THALASSEMIA: RESULTS FROM THE OPEN-LABEL PHASE 2 GLADIOLUS STUDY

EHA Library, Sujit Sheth, 4206851

SENESCENCE AND INFLAMMATION ARE UNINTENDED ADVERSE CONSEQUENCES OF CRISPR-CAS9/AAV6-MEDIATED GENE EDITING IN HEMATOPOIETIC STEM CELLS

EHA Library, Anastasia Conti, 4206836

SINGLE-CELL TRANSCRIPTOMICS-GUIDED FLOW CYTOMETRIC ANALYSIS OF INFLAMED MEGAKARYOCYTIC AND LYMPHOID PROGENITORS AT DIAGNOSIS IDENTIFIES CHRONIC PHASE CML AT HIGH RISK FOR BLAST CRISIS TRANSFORMATION

EHA Library, Tiong Ong, 4206710

MOLECULAR MECHANISM OF ZDHHC19-MEDIATED JAK1 PALMITOYLATION DRIVING TKIS RESISTANCE IN CML LEUKEMIA STEM CELLS

EHA Library, Teng Wang, 4206712

ALLOGENEIC HSCT FOR TP53-ABERRANT MYELOID NEOPLASMS: REAL-WORLD OUTCOMES FROM A SCANDINAVIAN MULTICENTRE COHORT

EHA Library, Anders Eivind Myhre, 4206827

LACK OF PROGNOSTIC IMPACT OF FLT3-ITD ON ALLOGENEIC TRANSPLANTATION OUTCOME IN AML WITH INV (16) (P13.1; Q22.1) OR T (16;16) (P13.1; Q22.1) ;(CBFB::MYH11): A STUDY ON BEHALF OF THE ALWP OF THE EBMT

EHA Library, Arnon Nagler, 4206826

POST-TRANSPLANT DYNAMICS OF DTA MUTATIONS AND THEIR ASSOCIATION WITH MOLECULAR RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Corinne Widmer, 4206824

7-KETOCHOLESTEROL REPROGRAMS T-CELL LINEAGE METABOLISM TO AMELIORATE STEROID-REFRACTORY ACUTE GVHD

EHA Library, Qingxiao Song, 4206816

DARATUMUMAB PLUS BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF TRANSPLANT-INELIGIBLE PATIENTS IN THE PHASE 3 CEPHEUS STUDY

EHA Library, Saad Z Usmani, 4206750

TECLISTAMAB PLUS DARATUMUMAB (TEC-DARA) IN PATIENTS (PTS) WITH RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM): ANALYSIS OF MAJESTEC-3 BASED ON CYTOGENETIC AND FUNCTIONAL RISK

EHA Library, Rahul Banerjee, 4206752

INTEGRATIVE MULTIMODAL PROFILING OF THE MICROBIOME-IMMUNE AXIS IN AUTOLOGOUS STEM CELL RECIPIENTS

EHA Library, Sabrina Becker, 4206815

TUMOR MICROENVIRONMENT WITH VASCULATURE-DRIVEN T-CELL EXHAUSTION IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA REVEALED BY SINGLE-CELL SPATIAL MULTI-OMICS

EHA Library, Yuki Shimizu, 4206807

CD20:CD3 T-CELL BISPECIFIC ANTIBODIES REPROGRAM THE TUMOR MICROENVIRONMENT AND SYNERGIZE WITH LYMPHOMA-TARGETED 4-1BB CO-STIMULATION IN PRECLINICAL DLBCL MODELS

EHA Library, Sergio Roa, 4206806

EFFICACY AND SAFETY OF LUSPATERCEPT IN PATIENTS WITH MYELOFIBROSIS ON JANUS KINASE INHIBITORS WHO REQUIRE RED BLOOD CELL TRANSFUSIONS: PRIMARY ANALYSIS OF THE PHASE 3 INDEPENDENCE TRIAL

EHA Library, Francesco Passamonti, 4206769

EARLY VERSUS DELAYED INITIATION OF ROPEGINTERFERON ALFA-2B IN HIGH-RISK ESSENTIAL THROMBOCYTHAEMIA: TWO-YEAR RESULTS FROM THE PHASE 3 SURPASS-ET STUDY

EHA Library, Harinder gILL, 4206773

BRAIN-LYM: DEFINING IMMUNE-MOLECULAR PHENOTYPES IN PRIMARY CNS LYMPHOMA

EHA Library, Fleur de Groot, 4206804

COMPREHENSIVE ANALYSIS OF BRIDGING TO CAR T-CELL THERAPY IN LARGE B-CELL LYMPHOMA WITH CONVENTIONAL TREATMENT OR CD3XCD20 BISPECIFIC ANTIBODIES

EHA Library, Ruth Fluemann, 4206795

RESULTS OF AJX-101, A PHASE 1 CLINICAL TRIAL OF THE TYPE II JAK2 INHIBITOR AJ1-11095, IN PATIENTS WITH MYELOFIBROSIS WHO HAVE BEEN FAILED BY A TYPE I JAK2 INHIBITOR

EHA Library, John Mascarenhas, 4206772

FAVORABLE REAL-WORLD OUTCOMES AFTER CD19 CAR T CELL TREATMENT IN RELAPSED/REFRACTORY HIGH-GRADE B-CELL LYMPHOMAS (HGBL): AN EBMT LWP ANALYSIS

EHA Library, Igor Age Kos, 4206797

TUMOUR MICROENVIRONMENT ARCHETYPES THAT SUPPORT ANTI-TUMOUR T-CELL IMMUNITY AND CD4⁺ T-CELL CYTOTOXIC DIFFERENTIATION UNDERPIN RESPONSE TO GLOFITAMAB IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Thiago M Steiner, 4206798

HMGA1 STABILIZES MYC PROTEIN TO DRIVE ONCOGENIC TRANSCRIPTIONAL PROGRAMS IN TRANSFORMED FOLLICULAR LYMPHOMA (FL)

EHA Library, Androniki Michaelou, 4206808

MUTANT CALRETICULIN–SPECIFIC MONOCLONAL ANTIBODY, INCA033989, IS WELL TOLERATED AND ACHIEVES ROBUST SPLEEN, ANEMIA, AND MOLECULAR RESPONSES IN PATIENTS (PTS) WITH MYELOFIBROSIS (MF)

EHA Library, Claire HARRISON, 4206770

TECLISTAMAB  (TEC) +/- LENALIDOMIDE (LEN) VERSUS LEN ALONE AS MAINTENANCE THERAPY POST-TRANSPLANT IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): UPDATED SAFETY RUN-IN (SRI) RESULTS FROM EMN30/MAJESTEC-4

EHA Library, Niels W. C. J. van de donk, 4206751

INTEGRATED METABOLIC AND EPIGENETIC PROFILING UNCOVERS DISTINCT IMMUNE‑ESCAPE PROGRAMS AND TARGETABLE VULNERABILITIES IN POST‑TRANSPLANT AML RELAPSE

EHA Library, Annalisa Tameni, 4206814

TRIM5 DRIVES T CELL PATHOGENICITY IN GRAFT-VERSUS-HOST DISEASE THROUGH SLC25A35 UBIQUITINATION

EHA Library, Qiao Cheng, 4206817

A LIVING THERAPEUTIC PLATFORM FOR LOCALIZED IN SITU MODULATION OF MACROPHAGE PYROPTOSIS AMELIORATES GVHD WHILE PRESERVING GVL

EHA Library, Zhuo Wan, 4206818

REFINING PROGNOSTIC STRATIFICATION FOR SAML POST-ALLO-HSCT: VALIDATION OF ELN 2022 AND PREDOMINANT ROLE OF MDS-RELATED CYTOGENETICS.

EHA Library, Nan Yang, 4206825

A GENETIC–CLINICAL PROGNOSTIC ALGORITHM FOR RISK STRATIFICATION IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA UNDERGOING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yue Jin, 4206828

MULTIPLEX PRIME EDITING ENABLES SAFE, DRUG-CONTROLLABLE, AND IMMUNOSUPPRESSION-RESISTANT T-CELL THERAPIES

EHA Library, Thomas Lew, 4206834

INTEGRATED MULTI-OMIC PROFILING IDENTIFIES GENOMIC SUBTYPES ASSOCIATED WITH DIFFERENTIAL OUTCOMES AFTER CAR-T THERAPY IN LARGE B-CELL LYMPHOMA

EHA Library, Silvia Escribano Serrat, 4206837

BRANCHED-CHAIN AMINO ACID BIOAVAILABILITY DURING CD19 CAR T-CELL EXPANSION ASSOCIATES WITH FAVORABLE T-CELL STATES AND CLINICAL RESPONSE IN LBCL

EHA Library, Sylvain Lamure, 4206838

MAJESTEC-9: A PHASE 3 STUDY OF TECLISTAMAB MONOTHERAPY VS POMALIDOMIDE/BORTEZOMIB/DEXAMETHASONE OR CARFILZOMIB/DEXAMETHASONE (PVD/KD) IN PATIENTS (PTS) WITH RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Cyrille Touzeau, 4206749

INTEGRATED GENOMIC AND TRANSCRIPTOMIC ANALYSES REVEAL BIOLOGICAL HETEROGENEITY OF ACCELERATED-PHASE CHRONIC MYELOID LEUKEMIA AND IDENTIFY A BLAST-PHASE-LIKE SUBGROUP

EHA Library, Xiaoshuai Zhang, 4206713

INFLUENCE OF NON-BCR::ABL1 SOMATIC MUTATIONS ON TYROSINE KINASE INHIBITOR (TKI) RESISTANCE IN CHRONIC MYELOID LEUKEMIA

EHA Library, Michele Ciboddo, 4206711

SINGLE-CELL GENETIC LINEAGE TRACING REVEALS PRE-EXISTING BLAST CRISIS-INITIATING CLONES AT CHRONIC PHASE CML DIAGNOSIS

EHA Library, Elaine Cao, 4206709

ANTIBODY-BASED IMMUNOTHERAPY VERSUS CELLULAR THERAPY AS BRIDGING TO ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY OR MRD-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ao-ran Zhang, 4206665

LONG-TERM OUTCOMES OF NATURALLY SELECTED CD7 CAR-T THERAPY IN RELAPSED/REFRACTORY T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA: A COHORT OF 171 PATIENTS

EHA Library, Xian Zhang, 4206664

REPLACEMENT OF HIGH DOSE COMBINATION CHEMOTHERAPY WITH BLINATUMOMAB IN NEWLY DIAGNOSED PEDIATRIC HIGH-RISK B-CELL ALL IMPROVES EFFICACY AND SAFETY IN THE RANDOMIZED PHASE 3 AIEOP-BFM ALL 2017 TRIAL

EHA Library, Martin Schrappe, 4206657

EFFICACY AND SAFETY OF ORAL TETRAHYDROURIDINE-DECITABINE (NDEC) IN ADULTS WITH SICKLE CELL DISEASE: RESULTS FROM THE PHASE 2, GLOBAL, RANDOMIZED, PARALLEL-GROUP ASCENT1 TRIAL

EHA Library, Biree Andemariam, 4206849

LONG-TERM HEMOGLOBIN IMPROVEMENTS IN NON–TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA: RESULTS FROM THE OPEN-LABEL EXTENSION OF THE ONGOING PHASE 3 ENERGIZE TRIAL

EHA Library, Hanny Al-Samkari, 4206850

EFFICACY AND SAFETY OF MITAPIVAT IN SICKLE CELL DISEASE: RESULTS FROM THE GLOBAL, RANDOMIZED, PHASE 3 RISE UP TRIAL

EHA Library, Biree Andemariam, 4206656

PHASE 3, RANDOMIZED STUDY OF TALQUETAMAB (TAL) PLUS DARATUMUMAB (DARA) ± POMALIDOMIDE (POM) VS DARA PLUS POM AND DEXAMETHASONE (DPD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): MONUMENTAL-3

EHA Library, Peter Voorhees, 4206654